当前位置:易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型:会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累,可浏览访问
(41-90)良好信誉积累,可接洽商谈
(91+ )优质信誉积累,可持续信赖
易推广会员:5年
最后认证时间:
注册号: 【已认证】
法人代表: 【已认证】
企业类型:生产商 【已认证】
注册资金:人民币万 【已认证】
产品数:86101
参观次数:3236317
已选条件
-
T76912Atorolimumab;化合物 AtorolimumabAtorolimumab
Atorolimumab (P3x22914G4), a monoclonal antibody, is employed in immunotherapies that target the programmed death-1 (PD-1) receptor [1].
价 格:¥电议型 号:T76912产 地:中国大陆
-
T76910Astegolimab;艾特利单抗RG 6149|||MSTT 1041A;RG 6149|||MSTT 1041A
Astegolimab (RG 6149) is a humanised IgG2 monoclonal antibody that targets the IL-33 receptor and inhibits IL-33 signalling. Astegolimab is used in the study of chronic obstructive pulmonary disease (COPD) and severe asthma in adults.
价 格:¥电议型 号:T76910产 地:中国大陆
-
T76909Apolizumab;化合物 ApolizumabApolizumab
Apolizumab (Hu1D10), a humanized monoclonal antibody targeting the Human leukocyte antigen-DR beta-chain, has been shown to induce apoptosis in chronic lymphocytic leukemia (CLL) cells in vitro [1] [2].
价 格:¥电议型 号:T76909产 地:中国大陆
-
T76908Anumigilimab;化合物 AnumigilimabAnumigilimab
Anumigilimab (CSL-324) is a humanized IgG2a monoclonal antibody (mAb) targeting the human granulocyte colony-stimulating factor (G-CSF) receptor, utilized to elevate neutrophil counts at inflammation sites [1] [2].
价 格:¥电议型 号:T76908产 地:中国大陆
-
T76907Palivizumab;帕利珠单抗Synagis|||MEDI 493;Synagis|||MEDI 493
Palivizumab (MEDI 493) is a humanized RSV-specific monoclonal antibody that selectively inhibits epitopes at the F protein A antigenic site of RSV subtypes A and B for the prevention of respiratory syncytial virus infection (RSV).
价 格:¥电议型 号:T76907产 地:中国大陆
-
T76906Anrukinzumab;化合物 AnrukinzumabAnrukinzumab
Anrukinzumab (IMA-638), a humanized anti-IL-13 monoclonal antibody, effectively reduces lung inflammation in cynomolgus monkeys and shows potential in the studies of ulcerative colitis (UC) and asthma [1] [2] [3].
价 格:¥电议型 号:T76906产 地:中国大陆
-
T76905Anbenitamab;化合物 AnbenitamabAnbenitamab
Anbenitamab (KN-026) is a bispecific antibody that targets extracellular domains II and IV of human HER2, blocking both ligand-dependent and independent signaling pathways. Its IgG1 Fc fragment activates FcRγIIIa, triggering strong antibody-dependent cell-mediated cytotoxicity (ADCC) and suppressing tumor cell growth. Anbenitamab shows promise for research in HER2-positive metastatic breast cancer (MBC) [1] [2].
价 格:¥电议型 号:T76905产 地:中国大陆
-
T76904Amubarvimab;化合物 AmubarvimabAmubarvimab
Amubarvimab (BRII-196), a human IgG1 monoclonal antibody (mAb), targets non-competing epitopes on the receptor binding domain (RBD) of the spike protein, exhibiting a dissociation constant (K D) of 5.88 nM. It has demonstrated efficacy in neutralizing SARS-CoV-2 variants [1] [2].
价 格:¥电议型 号:T76904产 地:中国大陆
-
T76902Afelimomab;化合物 AfelimomabAfelimomab
Afelimomab (MAK 195F), a F(ab´)2 fragment of an anti-tumor necrosis factor monoclonal antibody, is utilized in sepsis research [1].
价 格:¥电议型 号:T76902产 地:中国大陆
-
T76901Afasevikumab;化合物 AfasevikumabAfasevikumab
Afasevikumab (RG 7624; RO 5553110; NI-1401), a fully human monoclonal IgG1κ antibody, neutralizes both IL-17A and IL-17F, exhibiting anti-inflammatory activities [1].
价 格:¥电议型 号:T76901产 地:中国大陆
-
T76900Adintrevimab;化合物 AdintrevimabAdintrevimab
Adintrevimab (ADG 20), a human IgG1 monoclonal antibody, targets SARS-CoV (SARS-CoV) and demonstrates inhibition against SARS-CoV-2 variants as well as other SARS-like coronaviruses with pandemic potential [1].
价 格:¥电议型 号:T76900产 地:中国大陆
-
T76899Adebrelimab;化合物 AdebrelimabAdebrelimab
Adebrelimab (SHR-1316), a humanized IgG4 monoclonal antibody targeting PD-L1 (PD-1/PD-L1), exhibits promising antitumor activity, notably in solid tumors and extensive-stage small-cell lung cancer (SCLC) [1] [2].
价 格:¥电议型 号:T76899产 地:中国大陆
-
T76898Adalimumab beta;化合物 Adalimumab betaAdalimumab beta
Adalimumab beta (ABP-501) is an anti-TNF-α monoclonal antibody utilized in the study of rheumatoid arthritis (RA) [1].
价 格:¥电议型 号:T76898产 地:中国大陆
-
T76897Acasunlimab;化合物 AcasunlimabAcasunlimab
Acasunlimab (GEN1046), a bispecific antibody (bsAb) designed to target PD-L1 and 4-1BB, functions by enhancing both T-cell and NK-cell response via conditional 4-1BB stimulation and continuously inhibiting the PD-1/PD-L1 axis. This compound is applicable in cancer research [1] [2].
价 格:¥电议型 号:T76897产 地:中国大陆
-
T76896Abrezekimab;阿泽奇单抗UCB4144|||VR 942;UCB4144|||VR 942
Abrezekimab (VR 942) is composed of CDP7766, leucine, and trehalose. Abrezekimab is a humanized antibody that targets human IL-13. Abrezekimab inhibits binding to IL-13Rα1 subunit. Abrezekimab can be used to study biological disorders associated with asthma and lung disease.
价 格:¥电议型 号:T76896产 地:中国大陆
-
T76894Abelacimab;化合物 AbelacimabAbelacimab
Abelacimab (MAA868), a fully human IgG1 monoclonal antibody, targets and binds with high affinity to FXI´s catalytic structural domain. This interaction ensures FXI remains in its zymogen form, effectively inhibiting activation by FXIIa or thrombin. Such a mechanism underscores Abelacimab´s potential application in thromboembolic disease research [1] [2].
价 格:¥电议型 号:T76894产 地:中国大陆
-
T76893Lusvertikimab;化合物 LusvertikimabLusvertikimab
Lusvertikimab (OSE-127), a humanized IL7R monoclonal antibody, does not get internalized by target cells and inhibits IL7R heterodimerization along with subsequent downstream signaling. It demonstrates anti-leukemic properties and holds potential for research in B cell precursor acute lymphoblastic leukemia (BCP-ALL) [1].
价 格:¥电议型 号:T76893产 地:中国大陆
-
T76892Ordesekimab;奥司奇单抗AMG 714|||PRV-015;AMG 714|||PRV-015
Ordesekimab (AMG 714) is a human IgG1 κ-anti-IL-15 (Interleukin Related) monoclonal antibody. Ordesekimab binds competitively to IL-15, inhibiting the interaction of IL-15 with the common gamma chain of the IL-2Rβ and IL-15 receptor complex, but not with the IL-15Rα chain. Ordesekimab can be used to study non-reactive celiac disease (NRCD).
价 格:¥电议型 号:T76892产 地:中国大陆
-
T76891Oxelumab;奥塞芦单抗Ro 49-89991|||R 4930|||huMAb OX 40L;Ro 49-89991|||R 4930|||huMAb OX 40L
Oxelumab (R 4930) is a human monoclonal antibody for OX40L. Oxelumab could be used to study asthma.
价 格:¥电议型 号:T76891产 地:中国大陆
-
T76890Petosemtamab派森妥单抗MCLA 158
Petosemtamab (MCLA 158) is a highly potent monoclonal antibody against EGFR (Kd: 0.22 nM) and LGR5 (Kd: 0.86 nM). Petosemtamab promotes EGFR signaling disruption and receptor breakdown in LGR5+ cancer cells. Petosemtamab can be used in the study of solid tumors such as head and neck squamous cell carcinoma (HNSCC) and metastatic colorectal cancer (CRC).
价 格:¥电议型 号:T76890产 地:中国大陆